The ARC Training Centre for Cell and Tissue Engineering Technologies will allow Australia to deliver industry-aligned innovations resulting in the creation of human capital, next generation jobs, patents and spin-off companies in tissue engineering and regenerative medicine. This will strengthen the global competitiveness of the Australian tissue engineering and regenerative medicine industries as well as bring long-term health benefits to the Australian community.
To train a highly skilled, entrepreneurial, industry-ready workforce that is poised to consolidate the growing industry base of the tissue engineering and regenerative medicine sector and translate innovative technologies into commercialisation.
To develop technology solutions to advanced manufacturing, process efficiencies, monitoring and costs of goods along the product value chain, as well as new business models and approaches, which will elevate the delivery of these promising treatments for eventual health benefits.
To foster collaboration between academia and industry along the value chain for the tissue engineering and regenerative medicine sector.
To help companies accelerate delivery of real-world solutions in tissue engineering and regenerative medicine to the national and global market.
With an increasing an ageing population, Australia faces an increasing health burden. This Centre will work with industry to deliver various economic and health outcomes.